ATRC: AtriCure, Inc.
Performance
ATRC +80.28%
Watchlist
Select an item
Summary
ATRC at a glance
ATRC returned +80.28% over the past year and -7.87% a year over five years. Its worst drop in that year was -39.02%, smaller than 39% of stocks on Redstone, and its Sharpe ratio of 1.41 beats 90% of stocks on Redstone. It pays no dividends.
Current Drawdown
-11.83%
Rolling Volatility
49.25%
Actions
Metrics
Risk Indicators
Alpha60.66%
Beta0.62x
Sharpe1.41
Sortino2.14
Omega1.27
Calmar2.06
Martin3.20
Profile
About ATRC
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors.
- Sector
- Health Care
- Industry
- Surgical & Medical Instruments & Apparatus
- Market cap
- $2.9B
- Listed
- Aug 2005
- Employees
- 1,350
- Headquarters
- Mason, OH
- Website
- atricure.com
Comparisons